Publication | Open Access
A Phase I Study of α-Galactosylceramide (KRN7000)–Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
397
Citations
40
References
2005
Year
In this clinical trial, alphaGalCer-pulsed DC administration was well tolerated and could be safely done even in patients with advanced disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1